perc rule eligibility

PERC Rule Eligibility

The Pulmonary Embolism Rule-out Criteria (PERC) is a validated clinical decision rule designed to help healthcare professionals identify patients with a very low probability of pulmonary embolism (PE) who may not require further diagnostic testing. When applied appropriately, the PERC Rule can reduce unnecessary D-dimer testing and imaging while maintaining patient safety.

The PERC Rule is intended for use only after a clinician has already determined that the patient has a low pre-test probability of pulmonary embolism based on clinical judgement. It is not a diagnostic test and should not be used in patients with moderate or high clinical suspicion of PE.

Purpose of the PERC Rule

Pulmonary embolism is a potentially life-threatening condition that often presents with non-specific symptoms such as chest pain, shortness of breath, tachycardia, or syncope. Because these symptoms overlap with many other conditions, clinicians frequently use structured assessment tools to determine which patients require further investigation.

The PERC Rule helps identify low-risk patients in whom pulmonary embolism can be safely excluded without D-dimer testing or diagnostic imaging, provided that all eligibility criteria are satisfied.

PERC Rule Eligibility Criteria

To satisfy the PERC Rule, all of the following criteria must be met:

  • Age under 50 years
  • Heart rate below 100 beats per minute
  • Oxygen saturation of 95% or greater on room air
  • No unilateral leg swelling
  • No haemoptysis
  • No recent surgery or trauma requiring hospitalisation
  • No previous deep vein thrombosis (DVT) or pulmonary embolism (PE)
  • No hormone use, including oestrogen-containing therapy

If any one of these criteria is not met, the PERC Rule is considered positive, and further assessment should be undertaken according to current clinical guidelines.

When Should the PERC Rule Be Used?

The PERC Rule should only be applied in patients who have already been assessed as having a low clinical probability of pulmonary embolism. Many clinicians first estimate pre-test probability using clinical judgement or validated prediction tools such as the Wells Score before considering PERC eligibility.

Patients with moderate or high clinical suspicion should proceed directly to appropriate diagnostic investigation rather than relying on the PERC Rule.

Clinical Applications

The PERC Rule is widely used in:

  • Emergency Departments
  • Acute Medical Units
  • Urgent Care Centres
  • Emergency Medicine
  • Primary Care (selected patients)

It has become an important component of evidence-based assessment strategies for suspected pulmonary embolism and has been incorporated into numerous emergency medicine protocols.

Limitations

Although the PERC Rule is highly useful in carefully selected patients, it is not appropriate for every clinical situation. It should not replace clinical judgement and should not be applied indiscriminately.

Healthcare professionals should exercise caution in patients with:

  • Moderate or high clinical suspicion of PE
  • Pregnancy
  • Significant cardiopulmonary disease
  • Persistent unexplained symptoms
  • Haemodynamic instability

Clinical judgement always takes precedence over any prediction rule.

PERC Rule and Clinical Decision-Making

The PERC Rule is often used alongside other validated assessment tools, including the Wells Score for Pulmonary Embolism and D-dimer testing, to provide a structured and evidence-based approach to evaluating patients with suspected venous thromboembolism.

At MediCalc, the PERC Rule Eligibility calculator is based on the original validated Pulmonary Embolism Rule-out Criteria and is designed to help healthcare professionals rapidly determine whether a low-risk patient meets all eligibility criteria. The calculator should always be interpreted within the context of a comprehensive clinical assessment, current clinical guidelines, and professional judgement.

When applied appropriately, the PERC Rule can safely reduce unnecessary investigations, minimise patient exposure to radiation and contrast media, and support efficient, evidence-based assessment of suspected pulmonary embolism.